Stable patients who stop taking beta-blockers a year or more after a heart attack fare no worse than those who keep taking them, a study conducted in South Korea finds.
United States (National)
Richard Mark Kirkner
Geo Focus
Coverage Attributes:
Beta
Data Driven:
37
%
Informative:
37
%
Cites Data:
15
%
Interviews Q&as:
7
%
Press Release:
1
%
Themes Covered:
Not enough data
Pitching Insights
Richard Mark Kirkner's coverage primarily focuses on medical research, treatment advancements, and FDA approvals in the healthcare and pharmaceutical sectors. The majority of his articles cite data, indicating an emphasis on evidence-based reporting.
Given this focus, Richard would likely be interested in pitches that offer access to new or proprietary data relevant to medical research or treatment outcomes. He may also be receptive to commentary from experts who can provide context and insights into the significance of recent scientific findings or clinical developments within these areas.
While there is no specific geographic focus mentioned for his coverage, it is important to note that his interest lies in scientifically rigorous topics related to healthcare and pharmaceuticals rather than regional health issues.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Principal Medical Writer
Publications
Most recent topics
Not enough data
